Nous utilisons des cookies pour vous offrir une meilleure expérience de navigation, analyser le trafic du site, personnaliser le contenu. Nous vous incitons à prendre connaissance de la manière dont nous utilisons les Cookies, ainsi que de notre Politique de confidentialité et de nos Conditions d’utilisation. Si vous continuez à utiliser le présent site, vous consentez à l’utilisation de cookies.

J’accepte

filtre de recherche

Communiqués de presse

Retrouvez tous nos derniers communiqués de presse. Restez informé des dernières actualités et des événements auxquels participe Curium.

5th mai 2021

RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®

4th mai 2021

Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.

28th avril 2021

Curium to Expand Noblesville Facility’s Workforce

23rd mars 2021

RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)

2nd mars 2021

Eckert & Ziegler’s GalliaPharm® distributed by Curium in France

26th janvier 2021

RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)

9th décembre 2020

RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)

8th septembre 2020

RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

9th juin 2020

Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe

24th mars 2020

Curium Announces Approval of Pulmotech^TM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

12th mars 2020

RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA

3rd mars 2020

Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

7th janvier 2020

RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application

2nd décembre 2019

Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

4th septembre 2019

Curium Announces Revised Pricing for Technescan MAG3^TM (kit for the preparation of technetium Tc 99m mertiatide)

9th janvier 2019

RadioMedix et Curium annoncent que le ⁶⁴Cu-Dotatate a reçu la désignation de Fast Track de la FDA.

3rd janvier 2019

Curium et Progenics annoncent leur collaboration en Europe pour le PyL™, traceur PET dédié au diagnostic du cancer de la prostate

27th août 2018

Curium et RadioMedix annoncent un accord mondial exclusif pour le développement de ⁶⁴Cu-Dotatate.

10th mai 2018

Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas

2nd mai 2018

Filtrer par

Communiqués de presse

RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®

Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.

Curium to Expand Noblesville Facility’s Workforce

RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)

Eckert & Ziegler’s GalliaPharm® distributed by Curium in France

RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe

Curium Announces Approval of Pulmotech^TM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA

Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application

Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

Curium Announces Revised Pricing for Technescan MAG3^TM (kit for the preparation of technetium Tc 99m mertiatide)

RadioMedix et Curium annoncent que le ⁶⁴Cu-Dotatate a reçu la désignation de Fast Track de la FDA.

Curium et Progenics annoncent leur collaboration en Europe pour le PyL™, traceur PET dédié au diagnostic du cancer de la prostate

Curium et RadioMedix annoncent un accord mondial exclusif pour le développement de ⁶⁴Cu-Dotatate.

Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas

Curium consolide sa position en France sur le marché TEP avec la finalisation de l’acquisition des activités opérationnelles de CycloPharma

Filtrer par

Communiqués de presse

RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®

Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.

Curium to Expand Noblesville Facility’s Workforce

RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)

Eckert & Ziegler’s GalliaPharm® distributed by Curium in France

RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)

RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe

Curium Announces Approval of PulmotechTM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA

Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application

Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

Curium Announces Revised Pricing for Technescan MAG3TM (kit for the preparation of technetium Tc 99m mertiatide)

RadioMedix et Curium annoncent que le 64Cu-Dotatate a reçu la désignation de Fast Track de la FDA.

Curium et Progenics annoncent leur collaboration en Europe pour le PyL™, traceur PET dédié au diagnostic du cancer de la prostate

Curium et RadioMedix annoncent un accord mondial exclusif pour le développement de 64Cu-Dotatate.

Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas

Curium consolide sa position en France sur le marché TEP avec la finalisation de l’acquisition des activités opérationnelles de CycloPharma

Curium Announces Approval of Pulmotech^TM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

Curium Announces Revised Pricing for Technescan MAG3^TM (kit for the preparation of technetium Tc 99m mertiatide)

RadioMedix et Curium annoncent que le ⁶⁴Cu-Dotatate a reçu la désignation de Fast Track de la FDA.

Curium et RadioMedix annoncent un accord mondial exclusif pour le développement de ⁶⁴Cu-Dotatate.